Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
03/1999
03/09/1999US5880091 Glycoprotein ligand for P-selectin and methods of use thereof
03/09/1999US5879952 43 Kd protein vaccine and method for the production thereof
03/09/1999US5879942 Processing enzyme for polypeptide
03/09/1999US5879941 Polypeptides and polynucleotides relating to the α-and β-subunits of a glutamate dehydrogenase and methods of use
03/09/1999US5879938 Ribozyme with increased activity by substitution of modified nucleotide into substrate binding arm or catalytic core
03/09/1999US5879936 Recombinant DNA methods, vectors and host cells
03/09/1999US5879926 Yeast strains for the production of mature heterologous proteins, especially hirudin
03/09/1999US5879925 Genetically engineered human immunodeficiency virus-like particles with modified chimeric envelope glycoproteins containing influenza virus transmembrane spanning domains
03/09/1999US5879914 Desulfurizing fossil fuels using transformed microorganism containing recombinant dna from rhodococcus which expresses biocatalyst
03/09/1999US5879911 Cell surface protein expressed on human cortical thymocyte and their use
03/09/1999US5879910 Hepatocyte growth factor protease domain variants
03/09/1999US5879908 CRFG-1a, a target and marker for chronic renal failure
03/09/1999US5879907 Artificial gene coding for authentic human serum albumin, use thereof and method
03/09/1999US5879906 Glucuronide repressors and uses thereof
03/09/1999US5879905 In vivo method of initiating protein synthesis with an amino acid other than methionine
03/09/1999US5879904 Nucleotide and peptide sequences of a hepatitis C virus isolate, diagnostic and therapeutic applications
03/09/1999US5879898 Antibodies specific for peptide corresponding to CD44 exon 6, and use of these antibodies for diagnosis of tumors
03/09/1999US5879896 Method of screening for inhibitors of human thyrotropin releasing hormone (TRH) receptor
03/09/1999US5879895 Recombinant bovine herpesvirus type 1 polypeptides and immunoassays
03/09/1999US5879893 Hybridization method for detecting polynucleotides coding for signal transduction inhibitor protein in body fluids and tissue samples; treatment of alzheimer's disease and cancer
03/09/1999US5879892 Relates to nucleic acid molecules and encoded polypeptides which are expressed preferentially in leukemia.
03/09/1999US5879883 Dna sequence coding for human amyloid protein having a point mutation in the transmembrane domain: non-isotopic dna assay for alzheimer's disease
03/09/1999US5879882 RNA probe for detecting c-fes MRNA
03/09/1999US5879879 Isolated dna molecule coding for regulatory enhancer for maximal induction of low density lipoprotein receptor gene following sterol depletion; anticholesterol agents
03/09/1999US5879687 Enhancing or eliciting cellular and/or humoral immune response, for treating tumors
03/09/1999US5879686 Administering refolded trimeric meningococcal group b porin protein-polysaccharide conjugate to raise immune response in animal
03/09/1999US5879677 Method for inhibition of cerebral tissue factor mediated reperfusion damage
03/09/1999US5879676 Bacillus thuringiensis strains active against lepidopteran and coleopteran pests
03/09/1999US5879673 Administration of thrombopoietin on a single day only
03/09/1999US5879672 Tie-2 ligand 1
03/09/1999US5879658 Technetium-99m labeled peptides for thrombus imaging
03/09/1999US5879657 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
03/09/1999US5879656 Radioactive therapeutic agent, receptor binding moiety
03/09/1999US5879340 Applicator system with suction control
03/09/1999CA2243656A1 Response regulator
03/09/1999CA2171970C A disease resistance gene from maize and its use for disease resistance as a selectable marker and as a gene identification probe
03/09/1999CA2105538C Differentially expressed leishmania genes and proteins
03/09/1999CA2080355C Isolated viral protein cytokine antagonists
03/09/1999CA2038279C Cd25 binding molecules
03/09/1999CA1340423C Mycobacterial recombinants and peptides
03/09/1999CA1340421C Sythesis of peptide aminoalkylamides and peptide hydrazides by the solid-phase method
03/08/1999CA2209893A1 Lantibiotic from streptococcus mutans, method of production and use thereof
03/04/1999WO1999010744A1 Diagnostic kit for skin tests, and method
03/04/1999WO1999010537A1 A tumor suppressor designated ts10q23.3
03/04/1999WO1999010516A2 Methods and compositions for therapies using genes encoding secreted proteins such as interferon-beta
03/04/1999WO1999010515A1 Baculovirus artificial chromosomes and methods of use
03/04/1999WO1999010514A1 Fumonosin resistance
03/04/1999WO1999010510A2 Fusion proteins comprising a dimerization, trimerization or tetramerization domain and an additional heterologous transcription activation, transcription repression, dna binding or ligand binding domain
03/04/1999WO1999010508A1 Chimeric transcriptional activators and compositions and uses related thereto
03/04/1999WO1999010506A1 Mosaic protein and restriction endonuclease assisted ligation method for making the same
03/04/1999WO1999010501A1 Apoptosis-associated nuclease cpan
03/04/1999WO1999010498A2 Genes encoding enzymes for lignin biosynthesis and uses thereof
03/04/1999WO1999010497A1 Novel mutants of gram negative mucosal bacteria and application thereof in vaccines
03/04/1999WO1999010496A1 Tuberculosis vaccine
03/04/1999WO1999010495A1 Cytokine designated lerk-6
03/04/1999WO1999010493A1 ATTENUATED AND DOMINANT NEGATIVE VARIANT cDNAs OF STAT6: STAT6b AND STAT6c
03/04/1999WO1999010492A1 Adipocyte-specific protein homologs
03/04/1999WO1999010491A1 New human g-protein coupled receptor
03/04/1999WO1999010490A1 Human galectin-9-like proteins and cdnas encoding these proteins
03/04/1999WO1999010489A1 Insect sequences for improving the efficiency of secretion of non-secreted proteins in eukaryotic cells
03/04/1999WO1999010487A2 Novel transcriptional regulators and uses therefor
03/04/1999WO1999010485A1 Methods using phage display for selecting internalizing ligands for gene delivery
03/04/1999WO1999010484A1 Rtd receptor
03/04/1999WO1999010480A2 New tissue-specific calpaines, their production and their use
03/04/1999WO1999010479A1 Impaired brca2 function in cells and non-human transgenic animals
03/04/1999WO1999010475A2 Attenuated strains of mycobacteria
03/04/1999WO1999010473A1 Growth promoting material for useful microorganisms and process for producing the same
03/04/1999WO1999010382A1 Peptides which elicit cytotoxic t cellular immunity
03/04/1999WO1999010381A1 Collagen mimics
03/04/1999WO1999010380A1 Human spa-1 protein and gene coding for the same
03/04/1999WO1999010379A1 Crystal of sm3 antibody (fragment) and recognizing epitope, its preparation, encoded data storage medium containing its coordinates and its diagnostical or medical use
03/04/1999WO1999010378A1 Pompilid wasp-derived neuropeptides
03/04/1999WO1999010377A1 Receptor for intestinal trefoil factor
03/04/1999WO1999010375A2 Vaccine against hpv
03/04/1999WO1999010372A1 Molecular mimetics of meningococcal b epitopes
03/04/1999WO1999010370A1 A simple, environmentally benign, method for purifying protein a
03/04/1999WO1999010369A1 Compositions, kits, and methods for effecting adenine nucleotide modulation of dna mismatch recognition proteins
03/04/1999WO1999010368A1 Presenilin-1 gene promoter
03/04/1999WO1999010367A1 Dna molecules encoding human nuclear receptor proteins
03/04/1999WO1999010364A1 Follistatin-3
03/04/1999WO1999010363A1 29 human secreted proteins
03/04/1999WO1999010358A2 Method for producing nucleic acid polymers
03/04/1999WO1999010014A2 Receptor-mediated gene delivery using bacteriophage vectors
03/04/1999WO1999010013A1 The use of insulin-like growth factor-i in muscle
03/04/1999WO1999010012A1 NOVEL priA
03/04/1999WO1999010005A1 Vaccines for chlamydia psittaci infections
03/04/1999WO1999010001A1 Carcinostatic agents
03/04/1999WO1999009835A1 Use of an anti-microbial composition
03/04/1999WO1999009816A1 Process for producing insulin precursor proteins
03/04/1999WO1999009815A1 Vitamin d receptor ablated mice
03/04/1999WO1998056915A3 Artificial antibody polypeptides
03/04/1999WO1998056902A3 Transgenic fish with tissue-specific expression
03/04/1999WO1998056811A3 Plant grab proteins
03/04/1999WO1998055873A3 Use of a fluorescent protein for detecting interaction between a target protein and its ligand
03/04/1999WO1998055641A3 Somatic gene therapy to suppress secondary cataract formation
03/04/1999WO1998055639A3 Recombinant adenoviral vectors comprising a splicing sequence
03/04/1999WO1998055626A3 Recombinant porcine reproductive and respiratory syndrome virus (prrsv) for use as a vaccine
03/04/1999WO1998055616A3 Brca2 locus-associated protein
03/04/1999WO1998055607A3 Tumor targeted vector
03/04/1999WO1998055606A3 Lactoferrin receptor genes of moraxella
1 ... 2303 2304 2305 2306 2307 2308 2309 2310 2311 2312 2313 2314 2315 2316 2317 2318 2319 2320 2321 2322 2323 ... 2916